Digestive Remedies in Brazil

  • ID: 316778
  • Report
  • Region: Brazil
  • 19 pages
  • Euromonitor International
1 of 4
ANVISA is expected to approve switches of some substances that are globally considered OTC in the short term, maybe at the end of 2017. This approval should include substances such as omeprazole, classified under proton pump inhibitors, which is still sold through prescription drugs in Brazil. Consequently, sales of digestive remedies should significantly increase in part thanks to this switch during the forecast period.

The Digestive Remedies in Brazil report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2012-2016, allowing you to identify the sectors driving growth. Forecasts to 2021 illustrate how the market is set to change.

Product coverage: Diarrhoeal Remedies, IBS Treatments, Indigestion and Heartburn Remedies, Laxatives, Motion Sickness Remedies, Paediatric Digestive Remedies.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Digestive Remedies market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Note: Product cover images may vary from those shown
2 of 4
DIGESTIVE REMEDIES IN BRAZIL

List of Contents and Tables:
  • Headlines
  • Prospects
  • Switches Should Positively Impact Sales of Digestive Remedies in the Short Term
  • Stress and Unhealthy Eating Habits Will Drive Demand for Antacids and Laxatives
  • Innovations, Marketing Tools and Focus on Younger Consumers Set To Drive Future Sales
  • Competitive Landscape
  • GlaxoSmithKline Brasil Leads, Sanofi-aventis Follows
  • Multinationals Lead, But Important Domestic Companies Also Fill Top Places
  • Award-winning Hypermarcas Is the Biggest Pharmaceutical Advertiser in the Country
  • Category Data
  • Table 1 Sales of Digestive Remedies by Category: Value 2012-2017
  • Table 2 Sales of Digestive Remedies by Category: % Value Growth 2012-2017
  • Table 3 NBO Company Shares of Digestive Remedies: % Value 2013-2017
  • Table 4 LBN Brand Shares of Digestive Remedies: % Value 2014-2017
  • Table 5 Forecast Sales of Digestive Remedies by Category: Value 2017-2022
  • Table 6 Forecast Sales of Digestive Remedies by Category: % Value Growth 2017-2022
  • Executive Summary
  • Consumer Health Grows in Spite of the Economic Slowdown in 2017
  • 2017 Consumer Health Value Growth Slows Compared To the Review Period
  • Changes in Competitive Landscape After Global Acquisitions
  • Leading OTC Players Are Expected To Recover Space in Drugstores
  • Positive Outlook Is Expected
  • Market Indicators
  • Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2012-2017
  • Table 8 Life Expectancy at Birth 2012-2017
  • Market Data
  • Table 9 Sales of Consumer Health by Category: Value 2012-2017
  • Table 10 Sales of Consumer Health by Category: % Value Growth 2012-2017
  • Table 11 NBO Company Shares of Consumer Health: % Value 2013-2017
  • Table 12 LBN Brand Shares of Consumer Health: % Value 2014-2017
  • Table 13 Distribution of Consumer Health by Format: % Value 2012-2017
  • Table 14 Distribution of Consumer Health by Format and Category: % Value 2017
  • Table 15 Forecast Sales of Consumer Health by Category: Value 2017-2022
  • Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2017-2022
  • Appendix
  • OTC Registration and Classification
  • Vitamins and Dietary Supplements Registration and Classification
  • Self-medication/self-care and Preventive Medicine
  • Switches
  • Definitions
  • Sources
  • Summary 1 Research Sources
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
CH06drBR
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll